nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoflurane—ALB—Vismodegib—skin cancer	0.193	0.361	CbGbCtD
Isoflurane—ALB—Vemurafenib—skin cancer	0.153	0.285	CbGbCtD
Isoflurane—CYP2E1—Dacarbazine—skin cancer	0.121	0.226	CbGbCtD
Isoflurane—ALB—Fluorouracil—skin cancer	0.0686	0.128	CbGbCtD
Isoflurane—GABRQ—nerve—skin cancer	0.0129	0.044	CbGeAlD
Isoflurane—GRIA1—nerve—skin cancer	0.0117	0.0398	CbGeAlD
Isoflurane—KCNA1—nerve—skin cancer	0.0114	0.0389	CbGeAlD
Isoflurane—ATP2C1—skin epidermis—skin cancer	0.00939	0.032	CbGeAlD
Isoflurane—ATP2C1—nerve—skin cancer	0.008	0.0272	CbGeAlD
Isoflurane—CALM2—ear—skin cancer	0.00735	0.025	CbGeAlD
Isoflurane—CALM1—ear—skin cancer	0.00732	0.0249	CbGeAlD
Isoflurane—ATP2C1—hair follicle—skin cancer	0.0067	0.0228	CbGeAlD
Isoflurane—Traumatic liver injury—Temozolomide—skin cancer	0.00595	0.0623	CcSEcCtD
Isoflurane—ND1—neck—skin cancer	0.00565	0.0192	CbGeAlD
Isoflurane—GABRE—hair follicle—skin cancer	0.00501	0.0171	CbGeAlD
Isoflurane—CALM2—nerve—skin cancer	0.00463	0.0158	CbGeAlD
Isoflurane—CALM1—nerve—skin cancer	0.00461	0.0157	CbGeAlD
Isoflurane—ATP5D—nipple—skin cancer	0.0046	0.0157	CbGeAlD
Isoflurane—GABRA3—neck—skin cancer	0.00455	0.0155	CbGeAlD
Isoflurane—ATP2C1—nipple—skin cancer	0.00454	0.0155	CbGeAlD
Isoflurane—GABRP—nipple—skin cancer	0.00445	0.0152	CbGeAlD
Isoflurane—KCNK3—female reproductive system—skin cancer	0.00412	0.014	CbGeAlD
Isoflurane—CALM2—endothelium—skin cancer	0.00394	0.0134	CbGeAlD
Isoflurane—CALM1—endothelium—skin cancer	0.00392	0.0134	CbGeAlD
Isoflurane—CALM2—hair follicle—skin cancer	0.00387	0.0132	CbGeAlD
Isoflurane—KCNK10—head—skin cancer	0.00381	0.013	CbGeAlD
Isoflurane—KCNK9—head—skin cancer	0.00379	0.0129	CbGeAlD
Isoflurane—ND1—skin of body—skin cancer	0.00366	0.0125	CbGeAlD
Isoflurane—CALM2—blood vessel—skin cancer	0.00363	0.0124	CbGeAlD
Isoflurane—CALM1—blood vessel—skin cancer	0.00362	0.0123	CbGeAlD
Isoflurane—KCNK3—head—skin cancer	0.00344	0.0117	CbGeAlD
Isoflurane—GABRE—nipple—skin cancer	0.0034	0.0116	CbGeAlD
Isoflurane—CALM3—nipple—skin cancer	0.00334	0.0114	CbGeAlD
Isoflurane—ATP5D—connective tissue—skin cancer	0.00326	0.0111	CbGeAlD
Isoflurane—Necrosis—Dactinomycin—skin cancer	0.00312	0.0327	CcSEcCtD
Isoflurane—Hepatic function abnormal—Imiquimod—skin cancer	0.00307	0.0322	CcSEcCtD
Isoflurane—GABRQ—head—skin cancer	0.00307	0.0104	CbGeAlD
Isoflurane—GLRB—head—skin cancer	0.00298	0.0102	CbGeAlD
Isoflurane—ND1—lymphoid tissue—skin cancer	0.00296	0.0101	CbGeAlD
Isoflurane—ATP2C1—skin of body—skin cancer	0.00291	0.00991	CbGeAlD
Isoflurane—ND1—female reproductive system—skin cancer	0.00286	0.00973	CbGeAlD
Isoflurane—GRIA1—head—skin cancer	0.00277	0.00945	CbGeAlD
Isoflurane—KCNA1—head—skin cancer	0.00271	0.00922	CbGeAlD
Isoflurane—ATP5D—mammalian vulva—skin cancer	0.00269	0.00915	CbGeAlD
Isoflurane—GABRG3—head—skin cancer	0.00269	0.00915	CbGeAlD
Isoflurane—ATP2C1—mammalian vulva—skin cancer	0.00265	0.00903	CbGeAlD
Isoflurane—Liver injury—Temozolomide—skin cancer	0.00263	0.0276	CcSEcCtD
Isoflurane—CALM2—nipple—skin cancer	0.00263	0.00895	CbGeAlD
Isoflurane—GABRA4—mammalian vulva—skin cancer	0.00262	0.00892	CbGeAlD
Isoflurane—CALM1—nipple—skin cancer	0.00261	0.00891	CbGeAlD
Isoflurane—Necrosis—Fluorouracil—skin cancer	0.0026	0.0272	CcSEcCtD
Isoflurane—CALM2—neck—skin cancer	0.0026	0.00885	CbGeAlD
Isoflurane—CALM1—neck—skin cancer	0.00259	0.00881	CbGeAlD
Isoflurane—KCNK2—lymph node—skin cancer	0.0025	0.0085	CbGeAlD
Isoflurane—ND1—head—skin cancer	0.00239	0.00813	CbGeAlD
Isoflurane—ATP2C1—lymphoid tissue—skin cancer	0.00236	0.00802	CbGeAlD
Isoflurane—ATP5D—female reproductive system—skin cancer	0.0023	0.00784	CbGeAlD
Isoflurane—ATP2C1—female reproductive system—skin cancer	0.00227	0.00774	CbGeAlD
Isoflurane—GABRP—female reproductive system—skin cancer	0.00223	0.00758	CbGeAlD
Isoflurane—GABRD—head—skin cancer	0.00222	0.00758	CbGeAlD
Isoflurane—GABRG1—head—skin cancer	0.00214	0.00729	CbGeAlD
Isoflurane—GABRA6—head—skin cancer	0.00213	0.00725	CbGeAlD
Isoflurane—GLRB—lymph node—skin cancer	0.00209	0.00712	CbGeAlD
Isoflurane—Ileus—Docetaxel—skin cancer	0.00208	0.0218	CcSEcCtD
Isoflurane—GABRB1—head—skin cancer	0.00208	0.00707	CbGeAlD
Isoflurane—GABRA5—head—skin cancer	0.00207	0.00704	CbGeAlD
Isoflurane—GABRB3—connective tissue—skin cancer	0.00204	0.00696	CbGeAlD
Isoflurane—Cardiac disorder—Vemurafenib—skin cancer	0.00202	0.0212	CcSEcCtD
Isoflurane—GABRE—mammalian vulva—skin cancer	0.00198	0.00676	CbGeAlD
Isoflurane—Hepatic failure—Dactinomycin—skin cancer	0.00198	0.0207	CcSEcCtD
Isoflurane—Hepatobiliary disease—Imiquimod—skin cancer	0.00196	0.0205	CcSEcCtD
Isoflurane—Chills—Vemurafenib—skin cancer	0.00195	0.0205	CcSEcCtD
Isoflurane—CALM3—mammalian vulva—skin cancer	0.00195	0.00665	CbGeAlD
Isoflurane—GABRA3—head—skin cancer	0.00192	0.00655	CbGeAlD
Isoflurane—ATP5D—head—skin cancer	0.00192	0.00655	CbGeAlD
Isoflurane—ATP2C1—head—skin cancer	0.0019	0.00646	CbGeAlD
Isoflurane—Necrosis—Docetaxel—skin cancer	0.00188	0.0197	CcSEcCtD
Isoflurane—GABRA4—head—skin cancer	0.00187	0.00638	CbGeAlD
Isoflurane—CALM2—connective tissue—skin cancer	0.00186	0.00635	CbGeAlD
Isoflurane—GABRP—head—skin cancer	0.00186	0.00634	CbGeAlD
Isoflurane—CALM1—connective tissue—skin cancer	0.00185	0.00632	CbGeAlD
Isoflurane—Hepatic failure—Temozolomide—skin cancer	0.00179	0.0187	CcSEcCtD
Isoflurane—CALM2—epithelium—skin cancer	0.00177	0.00602	CbGeAlD
Isoflurane—CALM1—epithelium—skin cancer	0.00176	0.006	CbGeAlD
Isoflurane—GABRE—female reproductive system—skin cancer	0.0017	0.00579	CbGeAlD
Isoflurane—CALM2—skin of body—skin cancer	0.00168	0.00573	CbGeAlD
Isoflurane—CALM1—skin of body—skin cancer	0.00167	0.0057	CbGeAlD
Isoflurane—ND1—lymph node—skin cancer	0.00167	0.00569	CbGeAlD
Isoflurane—Chills—Imiquimod—skin cancer	0.00167	0.0174	CcSEcCtD
Isoflurane—Arrhythmia—Imiquimod—skin cancer	0.00166	0.0174	CcSEcCtD
Isoflurane—Cough—Vemurafenib—skin cancer	0.00165	0.0173	CcSEcCtD
Isoflurane—Bronchospasm—Bleomycin—skin cancer	0.00162	0.017	CcSEcCtD
Isoflurane—Vomiting—Vismodegib—skin cancer	0.00159	0.0167	CcSEcCtD
Isoflurane—Rash—Vismodegib—skin cancer	0.00158	0.0165	CcSEcCtD
Isoflurane—Dermatitis—Vismodegib—skin cancer	0.00158	0.0165	CcSEcCtD
Isoflurane—GABRG2—head—skin cancer	0.00157	0.00534	CbGeAlD
Isoflurane—GABRB2—head—skin cancer	0.00157	0.00534	CbGeAlD
Isoflurane—CALM2—mammalian vulva—skin cancer	0.00153	0.00523	CbGeAlD
Isoflurane—CALM1—mammalian vulva—skin cancer	0.00153	0.0052	CbGeAlD
Isoflurane—Nausea—Vismodegib—skin cancer	0.00149	0.0156	CcSEcCtD
Isoflurane—Agitation—Imiquimod—skin cancer	0.00149	0.0156	CcSEcCtD
Isoflurane—Hepatocellular injury—Docetaxel—skin cancer	0.00147	0.0154	CcSEcCtD
Isoflurane—Hypotension—Vemurafenib—skin cancer	0.00145	0.0151	CcSEcCtD
Isoflurane—GABRB3—female reproductive system—skin cancer	0.00144	0.00491	CbGeAlD
Isoflurane—GABRA2—head—skin cancer	0.00143	0.00488	CbGeAlD
Isoflurane—GABRE—head—skin cancer	0.00142	0.00484	CbGeAlD
Isoflurane—Cough—Imiquimod—skin cancer	0.00141	0.0148	CcSEcCtD
Isoflurane—Cardiac arrest—Fluorouracil—skin cancer	0.00141	0.0148	CcSEcCtD
Isoflurane—GABRA1—head—skin cancer	0.00138	0.00471	CbGeAlD
Isoflurane—CALM2—lymphoid tissue—skin cancer	0.00136	0.00464	CbGeAlD
Isoflurane—CALM1—lymphoid tissue—skin cancer	0.00136	0.00462	CbGeAlD
Isoflurane—ATP5D—lymph node—skin cancer	0.00135	0.00459	CbGeAlD
Isoflurane—ATP2C1—lymph node—skin cancer	0.00133	0.00453	CbGeAlD
Isoflurane—CALM2—female reproductive system—skin cancer	0.00131	0.00448	CbGeAlD
Isoflurane—CALM1—female reproductive system—skin cancer	0.00131	0.00445	CbGeAlD
Isoflurane—Hyperglycaemia—Temozolomide—skin cancer	0.00125	0.0131	CcSEcCtD
Isoflurane—CYP2B6—skin of body—skin cancer	0.00125	0.00426	CbGeAlD
Isoflurane—Hepatitis—Dactinomycin—skin cancer	0.00123	0.0129	CcSEcCtD
Isoflurane—Body temperature increased—Vemurafenib—skin cancer	0.00122	0.0128	CcSEcCtD
Isoflurane—GABRB3—head—skin cancer	0.0012	0.0041	CbGeAlD
Isoflurane—Hepatic failure—Docetaxel—skin cancer	0.00119	0.0125	CcSEcCtD
Isoflurane—Chills—Bleomycin—skin cancer	0.00118	0.0124	CcSEcCtD
Isoflurane—Hepatobiliary disease—Temozolomide—skin cancer	0.00117	0.0123	CcSEcCtD
Isoflurane—Hepatitis—Temozolomide—skin cancer	0.00111	0.0117	CcSEcCtD
Isoflurane—Hallucination—Temozolomide—skin cancer	0.00111	0.0116	CcSEcCtD
Isoflurane—Chills—Dactinomycin—skin cancer	0.0011	0.0116	CcSEcCtD
Isoflurane—CALM2—head—skin cancer	0.0011	0.00374	CbGeAlD
Isoflurane—CALM1—head—skin cancer	0.00109	0.00372	CbGeAlD
Isoflurane—Body temperature increased—Imiquimod—skin cancer	0.00104	0.0109	CcSEcCtD
Isoflurane—Cardiac disorder—Temozolomide—skin cancer	0.00103	0.0108	CcSEcCtD
Isoflurane—CYP2B6—lymphoid tissue—skin cancer	0.00101	0.00345	CbGeAlD
Isoflurane—GABRA2—lymph node—skin cancer	0.001	0.00342	CbGeAlD
Isoflurane—Cough—Bleomycin—skin cancer	0.001	0.0105	CcSEcCtD
Isoflurane—Chills—Temozolomide—skin cancer	0.000999	0.0105	CcSEcCtD
Isoflurane—GABRE—lymph node—skin cancer	0.000994	0.00339	CbGeAlD
Isoflurane—Vomiting—Vemurafenib—skin cancer	0.000984	0.0103	CcSEcCtD
Isoflurane—CALM3—lymph node—skin cancer	0.000979	0.00333	CbGeAlD
Isoflurane—CYP2B6—female reproductive system—skin cancer	0.000977	0.00333	CbGeAlD
Isoflurane—Rash—Vemurafenib—skin cancer	0.000975	0.0102	CcSEcCtD
Isoflurane—Dermatitis—Vemurafenib—skin cancer	0.000975	0.0102	CcSEcCtD
Isoflurane—CYP2E1—lymphoid tissue—skin cancer	0.00095	0.00324	CbGeAlD
Isoflurane—Nausea—Vemurafenib—skin cancer	0.000919	0.00962	CcSEcCtD
Isoflurane—CYP2E1—female reproductive system—skin cancer	0.000917	0.00312	CbGeAlD
Isoflurane—Arrhythmia—Fluorouracil—skin cancer	0.000916	0.00959	CcSEcCtD
Isoflurane—Bronchospasm—Docetaxel—skin cancer	0.00091	0.00952	CcSEcCtD
Isoflurane—ALB—lymph node—skin cancer	0.000906	0.00309	CbGeAlD
Isoflurane—Agitation—Temozolomide—skin cancer	0.00089	0.00932	CcSEcCtD
Isoflurane—Hypotension—Bleomycin—skin cancer	0.000876	0.00917	CcSEcCtD
Isoflurane—Cough—Temozolomide—skin cancer	0.000845	0.00885	CcSEcCtD
Isoflurane—Vomiting—Imiquimod—skin cancer	0.000839	0.00878	CcSEcCtD
Isoflurane—Rash—Imiquimod—skin cancer	0.000832	0.00871	CcSEcCtD
Isoflurane—Dermatitis—Imiquimod—skin cancer	0.000831	0.0087	CcSEcCtD
Isoflurane—CYP2B6—head—skin cancer	0.000816	0.00278	CbGeAlD
Isoflurane—Jaundice—Docetaxel—skin cancer	0.000804	0.00841	CcSEcCtD
Isoflurane—Nausea—Imiquimod—skin cancer	0.000784	0.00821	CcSEcCtD
Isoflurane—Hepatobiliary disease—Docetaxel—skin cancer	0.00078	0.00816	CcSEcCtD
Isoflurane—CALM2—lymph node—skin cancer	0.000769	0.00262	CbGeAlD
Isoflurane—CYP2E1—head—skin cancer	0.000766	0.00261	CbGeAlD
Isoflurane—CALM1—lymph node—skin cancer	0.000765	0.00261	CbGeAlD
Isoflurane—Body temperature increased—Bleomycin—skin cancer	0.000741	0.00776	CcSEcCtD
Isoflurane—Hepatitis—Docetaxel—skin cancer	0.00074	0.00775	CcSEcCtD
Isoflurane—Body temperature increased—Dactinomycin—skin cancer	0.000691	0.00724	CcSEcCtD
Isoflurane—Cardiac disorder—Docetaxel—skin cancer	0.000687	0.00719	CcSEcCtD
Isoflurane—Hypotension—Fluorouracil—skin cancer	0.000681	0.00713	CcSEcCtD
Isoflurane—Chills—Docetaxel—skin cancer	0.000664	0.00695	CcSEcCtD
Isoflurane—Arrhythmia—Docetaxel—skin cancer	0.000661	0.00692	CcSEcCtD
Isoflurane—Body temperature increased—Temozolomide—skin cancer	0.000625	0.00654	CcSEcCtD
Isoflurane—Vomiting—Bleomycin—skin cancer	0.000596	0.00624	CcSEcCtD
Isoflurane—Rash—Bleomycin—skin cancer	0.000591	0.00619	CcSEcCtD
Isoflurane—Dermatitis—Bleomycin—skin cancer	0.00059	0.00618	CcSEcCtD
Isoflurane—Body temperature increased—Fluorouracil—skin cancer	0.000576	0.00603	CcSEcCtD
Isoflurane—Cough—Docetaxel—skin cancer	0.000562	0.00589	CcSEcCtD
Isoflurane—Nausea—Bleomycin—skin cancer	0.000557	0.00583	CcSEcCtD
Isoflurane—Vomiting—Dactinomycin—skin cancer	0.000556	0.00582	CcSEcCtD
Isoflurane—Rash—Dactinomycin—skin cancer	0.000551	0.00577	CcSEcCtD
Isoflurane—Nausea—Dactinomycin—skin cancer	0.000519	0.00544	CcSEcCtD
Isoflurane—Vomiting—Temozolomide—skin cancer	0.000503	0.00526	CcSEcCtD
Isoflurane—Rash—Temozolomide—skin cancer	0.000499	0.00522	CcSEcCtD
Isoflurane—Dermatitis—Temozolomide—skin cancer	0.000498	0.00522	CcSEcCtD
Isoflurane—Hypotension—Docetaxel—skin cancer	0.000491	0.00514	CcSEcCtD
Isoflurane—Nausea—Temozolomide—skin cancer	0.00047	0.00492	CcSEcCtD
Isoflurane—Vomiting—Fluorouracil—skin cancer	0.000463	0.00485	CcSEcCtD
Isoflurane—Rash—Fluorouracil—skin cancer	0.000459	0.00481	CcSEcCtD
Isoflurane—Dermatitis—Fluorouracil—skin cancer	0.000459	0.00481	CcSEcCtD
Isoflurane—Nausea—Fluorouracil—skin cancer	0.000433	0.00453	CcSEcCtD
Isoflurane—Body temperature increased—Docetaxel—skin cancer	0.000416	0.00435	CcSEcCtD
Isoflurane—Vomiting—Docetaxel—skin cancer	0.000334	0.0035	CcSEcCtD
Isoflurane—Rash—Docetaxel—skin cancer	0.000332	0.00347	CcSEcCtD
Isoflurane—Dermatitis—Docetaxel—skin cancer	0.000331	0.00347	CcSEcCtD
Isoflurane—Nausea—Docetaxel—skin cancer	0.000312	0.00327	CcSEcCtD
Isoflurane—CALM1—Downstream signal transduction—HRAS—skin cancer	3.34e-05	0.000444	CbGpPWpGaD
Isoflurane—CALM2—Downstream signal transduction—HRAS—skin cancer	3.34e-05	0.000444	CbGpPWpGaD
Isoflurane—CALM3—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	3.34e-05	0.000444	CbGpPWpGaD
Isoflurane—CALM2—Signaling by FGFR—HRAS—skin cancer	3.33e-05	0.000442	CbGpPWpGaD
Isoflurane—CALM1—Signaling by FGFR—HRAS—skin cancer	3.33e-05	0.000442	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MC1R—skin cancer	3.32e-05	0.000441	CbGpPWpGaD
Isoflurane—CALM1—Signaling by ERBB2—HRAS—skin cancer	3.31e-05	0.00044	CbGpPWpGaD
Isoflurane—CALM2—Signaling by ERBB2—HRAS—skin cancer	3.31e-05	0.00044	CbGpPWpGaD
Isoflurane—CALM3—Downstream signal transduction—IL6—skin cancer	3.31e-05	0.00044	CbGpPWpGaD
Isoflurane—CALM2—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	3.3e-05	0.000438	CbGpPWpGaD
Isoflurane—CALM1—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	3.3e-05	0.000438	CbGpPWpGaD
Isoflurane—CALM1—DAP12 signaling—HRAS—skin cancer	3.29e-05	0.000438	CbGpPWpGaD
Isoflurane—CALM2—DAP12 signaling—HRAS—skin cancer	3.29e-05	0.000438	CbGpPWpGaD
Isoflurane—CALM3—Signaling by FGFR—IL6—skin cancer	3.29e-05	0.000438	CbGpPWpGaD
Isoflurane—CALM3—Signaling by ERBB2—IL6—skin cancer	3.27e-05	0.000435	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—GLI1—skin cancer	3.27e-05	0.000435	CbGpPWpGaD
Isoflurane—CALM1—Disease—SHH—skin cancer	3.26e-05	0.000434	CbGpPWpGaD
Isoflurane—CALM2—Disease—ENO2—skin cancer	3.26e-05	0.000434	CbGpPWpGaD
Isoflurane—CALM2—Disease—SHH—skin cancer	3.26e-05	0.000434	CbGpPWpGaD
Isoflurane—CALM1—Disease—ENO2—skin cancer	3.26e-05	0.000434	CbGpPWpGaD
Isoflurane—CALM3—DAP12 signaling—IL6—skin cancer	3.26e-05	0.000433	CbGpPWpGaD
Isoflurane—CALM1—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	3.23e-05	0.000429	CbGpPWpGaD
Isoflurane—CALM2—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	3.23e-05	0.000429	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MC1R—skin cancer	3.21e-05	0.000427	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MC1R—skin cancer	3.21e-05	0.000427	CbGpPWpGaD
Isoflurane—CALM3—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	3.2e-05	0.000426	CbGpPWpGaD
Isoflurane—CALM3—Signaling by FGFR in disease—HRAS—skin cancer	3.2e-05	0.000426	CbGpPWpGaD
Isoflurane—CALM3—DAP12 interactions—HRAS—skin cancer	3.2e-05	0.000426	CbGpPWpGaD
Isoflurane—CALM2—Downstream signal transduction—IL6—skin cancer	3.2e-05	0.000425	CbGpPWpGaD
Isoflurane—CALM1—Downstream signal transduction—IL6—skin cancer	3.2e-05	0.000425	CbGpPWpGaD
Isoflurane—CALM1—Signaling by FGFR—IL6—skin cancer	3.18e-05	0.000423	CbGpPWpGaD
Isoflurane—CALM2—Signaling by FGFR—IL6—skin cancer	3.18e-05	0.000423	CbGpPWpGaD
Isoflurane—CALM3—Signaling by EGFR—HRAS—skin cancer	3.17e-05	0.000422	CbGpPWpGaD
Isoflurane—CALM2—Signaling by ERBB2—IL6—skin cancer	3.17e-05	0.000421	CbGpPWpGaD
Isoflurane—CALM1—Signaling by ERBB2—IL6—skin cancer	3.17e-05	0.000421	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—GLI1—skin cancer	3.16e-05	0.000421	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—GLI1—skin cancer	3.16e-05	0.000421	CbGpPWpGaD
Isoflurane—CALM2—DAP12 signaling—IL6—skin cancer	3.15e-05	0.000419	CbGpPWpGaD
Isoflurane—CALM1—DAP12 signaling—IL6—skin cancer	3.15e-05	0.000419	CbGpPWpGaD
Isoflurane—CALM3—Signaling by EGFR in Cancer—HRAS—skin cancer	3.15e-05	0.000418	CbGpPWpGaD
Isoflurane—CALM3—Signaling by PDGF—HRAS—skin cancer	3.13e-05	0.000416	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SUFU—skin cancer	3.1e-05	0.000412	CbGpPWpGaD
Isoflurane—CALM2—DAP12 interactions—HRAS—skin cancer	3.1e-05	0.000412	CbGpPWpGaD
Isoflurane—CALM2—Signaling by FGFR in disease—HRAS—skin cancer	3.1e-05	0.000412	CbGpPWpGaD
Isoflurane—CALM1—Signaling by FGFR in disease—HRAS—skin cancer	3.1e-05	0.000412	CbGpPWpGaD
Isoflurane—CALM1—DAP12 interactions—HRAS—skin cancer	3.1e-05	0.000412	CbGpPWpGaD
Isoflurane—CALM2—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	3.1e-05	0.000412	CbGpPWpGaD
Isoflurane—CALM1—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	3.1e-05	0.000412	CbGpPWpGaD
Isoflurane—CALM2—Signaling by EGFR—HRAS—skin cancer	3.07e-05	0.000408	CbGpPWpGaD
Isoflurane—CALM1—Signaling by EGFR—HRAS—skin cancer	3.07e-05	0.000408	CbGpPWpGaD
Isoflurane—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	3.06e-05	0.000408	CbGpPWpGaD
Isoflurane—CALM3—Signaling by FGFR in disease—IL6—skin cancer	3.06e-05	0.000408	CbGpPWpGaD
Isoflurane—CALM3—DAP12 interactions—IL6—skin cancer	3.06e-05	0.000408	CbGpPWpGaD
Isoflurane—CALM1—Signaling by EGFR in Cancer—HRAS—skin cancer	3.04e-05	0.000405	CbGpPWpGaD
Isoflurane—CALM2—Signaling by EGFR in Cancer—HRAS—skin cancer	3.04e-05	0.000405	CbGpPWpGaD
Isoflurane—CALM3—Signaling by EGFR—IL6—skin cancer	3.04e-05	0.000404	CbGpPWpGaD
Isoflurane—CALM2—Signaling by PDGF—HRAS—skin cancer	3.03e-05	0.000403	CbGpPWpGaD
Isoflurane—CALM1—Signaling by PDGF—HRAS—skin cancer	3.03e-05	0.000403	CbGpPWpGaD
Isoflurane—CALM3—Signaling by EGFR in Cancer—IL6—skin cancer	3.01e-05	0.0004	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SUFU—skin cancer	3e-05	0.000399	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SUFU—skin cancer	3e-05	0.000399	CbGpPWpGaD
Isoflurane—CALM3—Signaling by PDGF—IL6—skin cancer	3e-05	0.000399	CbGpPWpGaD
Isoflurane—CALM3—Signaling by NGF—NRAS—skin cancer	2.98e-05	0.000397	CbGpPWpGaD
Isoflurane—CALM3—Immune System—FOXO4—skin cancer	2.98e-05	0.000396	CbGpPWpGaD
Isoflurane—CALM2—DAP12 interactions—IL6—skin cancer	2.96e-05	0.000394	CbGpPWpGaD
Isoflurane—CALM1—Signaling by FGFR in disease—IL6—skin cancer	2.96e-05	0.000394	CbGpPWpGaD
Isoflurane—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.96e-05	0.000394	CbGpPWpGaD
Isoflurane—CALM2—Signaling by FGFR in disease—IL6—skin cancer	2.96e-05	0.000394	CbGpPWpGaD
Isoflurane—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.96e-05	0.000394	CbGpPWpGaD
Isoflurane—CALM1—DAP12 interactions—IL6—skin cancer	2.96e-05	0.000394	CbGpPWpGaD
Isoflurane—CALM3—B Cell Activation—HRAS—skin cancer	2.96e-05	0.000394	CbGpPWpGaD
Isoflurane—CALM1—Signaling by EGFR—IL6—skin cancer	2.94e-05	0.000391	CbGpPWpGaD
Isoflurane—CALM2—Signaling by EGFR—IL6—skin cancer	2.94e-05	0.000391	CbGpPWpGaD
Isoflurane—CALM2—Signaling by EGFR in Cancer—IL6—skin cancer	2.91e-05	0.000387	CbGpPWpGaD
Isoflurane—CALM1—Signaling by EGFR in Cancer—IL6—skin cancer	2.91e-05	0.000387	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—ENO2—skin cancer	2.9e-05	0.000386	CbGpPWpGaD
Isoflurane—CALM3—Transmission across Chemical Synapses—HRAS—skin cancer	2.9e-05	0.000386	CbGpPWpGaD
Isoflurane—CALM1—Signaling by PDGF—IL6—skin cancer	2.9e-05	0.000386	CbGpPWpGaD
Isoflurane—CALM2—Signaling by PDGF—IL6—skin cancer	2.9e-05	0.000386	CbGpPWpGaD
Isoflurane—CALM2—Signaling by NGF—NRAS—skin cancer	2.88e-05	0.000384	CbGpPWpGaD
Isoflurane—CALM1—Signaling by NGF—NRAS—skin cancer	2.88e-05	0.000384	CbGpPWpGaD
Isoflurane—CALM1—Immune System—FOXO4—skin cancer	2.88e-05	0.000383	CbGpPWpGaD
Isoflurane—CALM2—Immune System—FOXO4—skin cancer	2.88e-05	0.000383	CbGpPWpGaD
Isoflurane—CALM2—B Cell Activation—HRAS—skin cancer	2.87e-05	0.000381	CbGpPWpGaD
Isoflurane—CALM1—B Cell Activation—HRAS—skin cancer	2.87e-05	0.000381	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—ENO2—skin cancer	2.84e-05	0.000378	CbGpPWpGaD
Isoflurane—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.84e-05	0.000377	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—ENO2—skin cancer	2.83e-05	0.000376	CbGpPWpGaD
Isoflurane—CALM2—Transmission across Chemical Synapses—HRAS—skin cancer	2.81e-05	0.000374	CbGpPWpGaD
Isoflurane—CALM1—Transmission across Chemical Synapses—HRAS—skin cancer	2.81e-05	0.000374	CbGpPWpGaD
Isoflurane—CALM3—Disease—FOXO4—skin cancer	2.75e-05	0.000366	CbGpPWpGaD
Isoflurane—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.74e-05	0.000365	CbGpPWpGaD
Isoflurane—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.74e-05	0.000365	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—ENO2—skin cancer	2.73e-05	0.000364	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—ENO2—skin cancer	2.73e-05	0.000364	CbGpPWpGaD
Isoflurane—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.71e-05	0.000361	CbGpPWpGaD
Isoflurane—CALM2—Disease—FOXO4—skin cancer	2.66e-05	0.000354	CbGpPWpGaD
Isoflurane—CALM1—Disease—FOXO4—skin cancer	2.66e-05	0.000354	CbGpPWpGaD
Isoflurane—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.63e-05	0.000349	CbGpPWpGaD
Isoflurane—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.63e-05	0.000349	CbGpPWpGaD
Isoflurane—CALM3—Signaling by NGF—KRAS—skin cancer	2.57e-05	0.000341	CbGpPWpGaD
Isoflurane—CALM2—Signaling by NGF—KRAS—skin cancer	2.48e-05	0.00033	CbGpPWpGaD
Isoflurane—CALM1—Signaling by NGF—KRAS—skin cancer	2.48e-05	0.00033	CbGpPWpGaD
Isoflurane—ALB—Metabolism—ENO2—skin cancer	2.44e-05	0.000325	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SHH—skin cancer	2.36e-05	0.000314	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—RASA1—skin cancer	2.35e-05	0.000312	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SHH—skin cancer	2.29e-05	0.000304	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SHH—skin cancer	2.29e-05	0.000304	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—RASA1—skin cancer	2.27e-05	0.000302	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—RASA1—skin cancer	2.27e-05	0.000302	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SMO—skin cancer	2.24e-05	0.000298	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PTCH1—skin cancer	2.24e-05	0.000298	CbGpPWpGaD
Isoflurane—CALM3—Neuronal System—HRAS—skin cancer	2.23e-05	0.000296	CbGpPWpGaD
Isoflurane—CALM3—Signaling by NGF—HRAS—skin cancer	2.18e-05	0.00029	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PTGER4—skin cancer	2.18e-05	0.00029	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SMO—skin cancer	2.17e-05	0.000288	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SMO—skin cancer	2.17e-05	0.000288	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PTCH1—skin cancer	2.17e-05	0.000288	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PTCH1—skin cancer	2.17e-05	0.000288	CbGpPWpGaD
Isoflurane—CALM1—Neuronal System—HRAS—skin cancer	2.15e-05	0.000286	CbGpPWpGaD
Isoflurane—CALM2—Neuronal System—HRAS—skin cancer	2.15e-05	0.000286	CbGpPWpGaD
Isoflurane—CALM1—Signaling by NGF—HRAS—skin cancer	2.11e-05	0.000281	CbGpPWpGaD
Isoflurane—CALM2—Signaling by NGF—HRAS—skin cancer	2.11e-05	0.000281	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PTGER4—skin cancer	2.11e-05	0.000281	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PTGER4—skin cancer	2.11e-05	0.000281	CbGpPWpGaD
Isoflurane—CALM3—Signaling by NGF—IL6—skin cancer	2.09e-05	0.000278	CbGpPWpGaD
Isoflurane—CALM2—Signaling by NGF—IL6—skin cancer	2.02e-05	0.000269	CbGpPWpGaD
Isoflurane—CALM1—Signaling by NGF—IL6—skin cancer	2.02e-05	0.000269	CbGpPWpGaD
Isoflurane—CALM3—Disease—ERCC2—skin cancer	1.96e-05	0.000261	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—FOXO4—skin cancer	1.93e-05	0.000256	CbGpPWpGaD
Isoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.91e-05	0.000254	CbGpPWpGaD
Isoflurane—CALM1—Disease—ERCC2—skin cancer	1.9e-05	0.000252	CbGpPWpGaD
Isoflurane—CALM2—Disease—ERCC2—skin cancer	1.9e-05	0.000252	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—NRAS—skin cancer	1.89e-05	0.000251	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—FOXO4—skin cancer	1.86e-05	0.000248	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—FOXO4—skin cancer	1.86e-05	0.000248	CbGpPWpGaD
Isoflurane—CALM3—Disease—TERT—skin cancer	1.84e-05	0.000244	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—NRAS—skin cancer	1.83e-05	0.000243	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—NRAS—skin cancer	1.83e-05	0.000243	CbGpPWpGaD
Isoflurane—CALM1—Disease—TERT—skin cancer	1.78e-05	0.000236	CbGpPWpGaD
Isoflurane—CALM2—Disease—TERT—skin cancer	1.78e-05	0.000236	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—NRAS—skin cancer	1.7e-05	0.000226	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—ERCC2—skin cancer	1.69e-05	0.000224	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—ERCC2—skin cancer	1.65e-05	0.00022	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—NRAS—skin cancer	1.65e-05	0.000219	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—NRAS—skin cancer	1.65e-05	0.000219	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—ERCC2—skin cancer	1.64e-05	0.000218	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—NRAS—skin cancer	1.63e-05	0.000217	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—NRAS—skin cancer	1.63e-05	0.000217	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—KRAS—skin cancer	1.63e-05	0.000216	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—ERCC2—skin cancer	1.59e-05	0.000211	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—ERCC2—skin cancer	1.59e-05	0.000211	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—NRAS—skin cancer	1.58e-05	0.00021	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—NRAS—skin cancer	1.58e-05	0.00021	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—KRAS—skin cancer	1.57e-05	0.000209	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—KRAS—skin cancer	1.57e-05	0.000209	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—KRAS—skin cancer	1.46e-05	0.000195	CbGpPWpGaD
Isoflurane—CALM3—Disease—BRAF—skin cancer	1.46e-05	0.000194	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—TP53—skin cancer	1.45e-05	0.000192	CbGpPWpGaD
Isoflurane—ALB—Metabolism—ERCC2—skin cancer	1.42e-05	0.000189	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—KRAS—skin cancer	1.42e-05	0.000188	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—KRAS—skin cancer	1.42e-05	0.000188	CbGpPWpGaD
Isoflurane—CALM1—Disease—BRAF—skin cancer	1.41e-05	0.000187	CbGpPWpGaD
Isoflurane—CALM2—Disease—BRAF—skin cancer	1.41e-05	0.000187	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—KRAS—skin cancer	1.41e-05	0.000187	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—KRAS—skin cancer	1.41e-05	0.000187	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—TP53—skin cancer	1.4e-05	0.000186	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—TP53—skin cancer	1.4e-05	0.000186	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—HRAS—skin cancer	1.38e-05	0.000184	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—KRAS—skin cancer	1.36e-05	0.000181	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—KRAS—skin cancer	1.36e-05	0.000181	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—HRAS—skin cancer	1.34e-05	0.000178	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—HRAS—skin cancer	1.34e-05	0.000178	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TERT—skin cancer	1.29e-05	0.000171	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—TP53—skin cancer	1.25e-05	0.000166	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TERT—skin cancer	1.24e-05	0.000166	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TERT—skin cancer	1.24e-05	0.000166	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—HRAS—skin cancer	1.24e-05	0.000165	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—HRAS—skin cancer	1.2e-05	0.00016	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—HRAS—skin cancer	1.2e-05	0.00016	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—HRAS—skin cancer	1.2e-05	0.000159	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—HRAS—skin cancer	1.19e-05	0.000159	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—IL6—skin cancer	1.19e-05	0.000158	CbGpPWpGaD
Isoflurane—CALM3—Disease—PTGS2—skin cancer	1.18e-05	0.000156	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—HRAS—skin cancer	1.16e-05	0.000154	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—HRAS—skin cancer	1.16e-05	0.000154	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—IL6—skin cancer	1.15e-05	0.000153	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—IL6—skin cancer	1.15e-05	0.000153	CbGpPWpGaD
Isoflurane—CALM1—Disease—PTGS2—skin cancer	1.14e-05	0.000151	CbGpPWpGaD
Isoflurane—CALM2—Disease—PTGS2—skin cancer	1.14e-05	0.000151	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—NRAS—skin cancer	1.08e-05	0.000144	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—NRAS—skin cancer	1.05e-05	0.000139	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—NRAS—skin cancer	1.05e-05	0.000139	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—BRAF—skin cancer	1.02e-05	0.000136	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PTGS2—skin cancer	1.01e-05	0.000135	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PTGS2—skin cancer	9.91e-06	0.000132	CbGpPWpGaD
Isoflurane—CALM3—Immune System—NRAS—skin cancer	9.91e-06	0.000132	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—BRAF—skin cancer	9.86e-06	0.000131	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—BRAF—skin cancer	9.86e-06	0.000131	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PTGS2—skin cancer	9.84e-06	0.000131	CbGpPWpGaD
Isoflurane—CALM2—Immune System—NRAS—skin cancer	9.58e-06	0.000127	CbGpPWpGaD
Isoflurane—CALM1—Immune System—NRAS—skin cancer	9.58e-06	0.000127	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PTGS2—skin cancer	9.52e-06	0.000127	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PTGS2—skin cancer	9.52e-06	0.000127	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—KRAS—skin cancer	9.33e-06	0.000124	CbGpPWpGaD
Isoflurane—CALM3—Disease—NRAS—skin cancer	9.15e-06	0.000122	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—KRAS—skin cancer	9.03e-06	0.00012	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—KRAS—skin cancer	9.03e-06	0.00012	CbGpPWpGaD
Isoflurane—CALM2—Disease—NRAS—skin cancer	8.85e-06	0.000118	CbGpPWpGaD
Isoflurane—CALM1—Disease—NRAS—skin cancer	8.85e-06	0.000118	CbGpPWpGaD
Isoflurane—CALM3—Immune System—KRAS—skin cancer	8.53e-06	0.000113	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PTGS2—skin cancer	8.51e-06	0.000113	CbGpPWpGaD
Isoflurane—CALM2—Immune System—KRAS—skin cancer	8.25e-06	0.00011	CbGpPWpGaD
Isoflurane—CALM1—Immune System—KRAS—skin cancer	8.25e-06	0.00011	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—HRAS—skin cancer	7.93e-06	0.000105	CbGpPWpGaD
Isoflurane—CALM3—Disease—KRAS—skin cancer	7.87e-06	0.000105	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—HRAS—skin cancer	7.67e-06	0.000102	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—HRAS—skin cancer	7.67e-06	0.000102	CbGpPWpGaD
Isoflurane—CALM2—Disease—KRAS—skin cancer	7.61e-06	0.000101	CbGpPWpGaD
Isoflurane—CALM1—Disease—KRAS—skin cancer	7.61e-06	0.000101	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—IL6—skin cancer	7.59e-06	0.000101	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—IL6—skin cancer	7.34e-06	9.77e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—IL6—skin cancer	7.34e-06	9.77e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—HRAS—skin cancer	7.25e-06	9.64e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—HRAS—skin cancer	7.01e-06	9.32e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—HRAS—skin cancer	7.01e-06	9.32e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—IL6—skin cancer	6.94e-06	9.22e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—IL6—skin cancer	6.71e-06	8.92e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—IL6—skin cancer	6.71e-06	8.92e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—HRAS—skin cancer	6.69e-06	8.9e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—HRAS—skin cancer	6.47e-06	8.61e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—HRAS—skin cancer	6.47e-06	8.61e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NRAS—skin cancer	6.4e-06	8.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—IL6—skin cancer	6.4e-06	8.52e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NRAS—skin cancer	6.2e-06	8.24e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NRAS—skin cancer	6.2e-06	8.24e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—IL6—skin cancer	6.19e-06	8.24e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—IL6—skin cancer	6.19e-06	8.24e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—KRAS—skin cancer	5.51e-06	7.33e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KRAS—skin cancer	5.33e-06	7.09e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KRAS—skin cancer	5.33e-06	7.09e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TP53—skin cancer	4.9e-06	6.52e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TP53—skin cancer	4.74e-06	6.3e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TP53—skin cancer	4.74e-06	6.3e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—HRAS—skin cancer	4.69e-06	6.23e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—HRAS—skin cancer	4.53e-06	6.03e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—HRAS—skin cancer	4.53e-06	6.03e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IL6—skin cancer	4.48e-06	5.96e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IL6—skin cancer	4.34e-06	5.77e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IL6—skin cancer	4.34e-06	5.77e-05	CbGpPWpGaD
